Milestone Scientific Announces Insurance Payment For The CompuFlo Epidural System
Portfolio Pulse from Benzinga Newsdesk
Milestone Scientific Inc. (NYSE:MLSS) has received positive reimbursement from three commercial payers for the use of its CompuFlo® Epidural System for patients involved in motor vehicle accidents. The payments are a significant achievement for the company, but do not yet confer broad coverage for other epidural procedures. The company remains focused on advancing positive reimbursement for the CompuFlo technology amongst all payers.
August 09, 2023 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Milestone Scientific's receipt of positive reimbursement for its CompuFlo® Epidural System from three commercial payers is a significant achievement, but does not yet confer broad coverage for other epidural procedures.
The news of Milestone Scientific receiving positive reimbursement for its CompuFlo® Epidural System is directly related to the company's revenue and product adoption. This could potentially lead to increased sales and wider adoption of the product, positively impacting the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100